moxonidine has been researched along with Weight Loss in 1 studies
moxonidine: structure given in first source
Weight Loss: Decrease in existing BODY WEIGHT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lambert, EA | 1 |
| Sari, CI | 1 |
| Eikelis, N | 1 |
| Phillips, SE | 1 |
| Grima, M | 1 |
| Straznicky, NE | 1 |
| Dixon, JB | 1 |
| Esler, M | 1 |
| Schlaich, MP | 1 |
| Head, GA | 1 |
| Lambert, GW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessment of the Effect of Moxonidine and Diet on Cardiac, Renal and Endothelial Function in Young Subjects With Abdominal Obesity[NCT01180231] | Phase 4 | 77 participants (Anticipated) | Interventional | 2010-09-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for moxonidine and Weight Loss
| Article | Year |
|---|---|
Effects of Moxonidine and Low-Calorie Diet: Cardiometabolic Benefits from Combination of Both Therapies.
Topics: Adolescent; Adult; Antihypertensive Agents; Caloric Restriction; Cardiovascular Diseases; Humans; Im | 2017 |